ACP-204 for Schizophrenia
This study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.
In France
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.
In FranceThis study is recruiting. It focuses on anxiety and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on PTSD and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on depression and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on PTSD and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on depression and currently lists participation information in France.
In FranceThis study is recruiting in France. It is testing SNOEZELEN Device on Anxiety Symptoms for anxiety.
In FranceThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on PTSD and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on PTSD and currently lists participation information in France.
In FranceThis study is recruiting. It focuses on PTSD and currently lists participation information in France.
In FranceThis study is recruiting in France. It focuses on anxiety.
In FranceHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.